229 related articles for article (PubMed ID: 15994303)
21. Protection of glioblastoma cells from cisplatin cytotoxicity via protein kinase Ciota-mediated attenuation of p38 MAP kinase signaling.
Baldwin RM; Garratt-Lalonde M; Parolin DA; Krzyzanowski PM; Andrade MA; Lorimer IA
Oncogene; 2006 May; 25(20):2909-19. PubMed ID: 16331246
[TBL] [Abstract][Full Text] [Related]
22. The oncogenic role of PKCiota gene amplification and overexpression in Chinese non-small cell lung cancer.
Luo Q; Tang L; Lin H; Huang J; Zhang T; Liu Y; Wang J; Zhan P; Yin X; Su X; Ji Q; Yu D; Xu L
Lung Cancer; 2014 May; 84(2):190-5. PubMed ID: 24636699
[TBL] [Abstract][Full Text] [Related]
23. Oncogenic protein kinase Cι signaling mechanisms in lung cancer: Implications for improved therapeutic strategies.
Yin N; Liu Y; Murray NR; Fields AP
Adv Biol Regul; 2020 Jan; 75():100656. PubMed ID: 31623973
[TBL] [Abstract][Full Text] [Related]
24. Targeting PKCι-PAK1 signaling pathways in EGFR and KRAS mutant adenocarcinoma and lung squamous cell carcinoma.
Ito M; Codony-Servat C; Codony-Servat J; Lligé D; Chaib I; Sun X; Miao J; Sun R; Cai X; Verlicchi A; Okada M; Molina-Vila MA; Karachaliou N; Cao P; Rosell R
Cell Commun Signal; 2019 Oct; 17(1):137. PubMed ID: 31660987
[TBL] [Abstract][Full Text] [Related]
25. The PRKCI and SOX2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinoma.
Justilien V; Walsh MP; Ali SA; Thompson EA; Murray NR; Fields AP
Cancer Cell; 2014 Feb; 25(2):139-51. PubMed ID: 24525231
[TBL] [Abstract][Full Text] [Related]
26. Survival function of protein kinase C{iota} as a novel nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-activated bad kinase.
Jin Z; Xin M; Deng X
J Biol Chem; 2005 Apr; 280(16):16045-52. PubMed ID: 15705582
[TBL] [Abstract][Full Text] [Related]
27. Recurrent copy number gains drive PKCι expression and PKCι-dependent oncogenic signaling in human cancers.
Liu Y; Justilien V; Fields AP; Murray NR
Adv Biol Regul; 2020 Dec; 78():100754. PubMed ID: 32992230
[TBL] [Abstract][Full Text] [Related]
28. Protein kinase Cι expression and oncogenic signaling mechanisms in cancer.
Murray NR; Kalari KR; Fields AP
J Cell Physiol; 2011 Apr; 226(4):879-87. PubMed ID: 20945390
[TBL] [Abstract][Full Text] [Related]
29. Protein kinase C
Kenchappa RS; Liu Y; Argenziano MG; Banu MA; Mladek AC; West R; Luu A; Quiñones-Hinojosa A; Hambardzumyan D; Justilien V; Leitges M; Sarkaria JN; Sims PA; Canoll P; Murray NR; Fields AP; Rosenfeld SS
Cell Rep; 2021 Nov; 37(8):110054. PubMed ID: 34818553
[TBL] [Abstract][Full Text] [Related]
30. Bcr-Abl regulates protein kinase Ciota (PKCiota) transcription via an Elk1 site in the PKCiota promoter.
Gustafson WC; Ray S; Jamieson L; Thompson EA; Brasier AR; Fields AP
J Biol Chem; 2004 Mar; 279(10):9400-8. PubMed ID: 14670960
[TBL] [Abstract][Full Text] [Related]
31. Conditional knockout of polarity complex (atypical) PKCι reveals an anti-inflammatory function mediated by NF-κB.
Forteza R; Figueroa Y; Mashukova A; Dulam V; Salas PJ
Mol Biol Cell; 2016 Jul; 27(14):2186-97. PubMed ID: 27226486
[TBL] [Abstract][Full Text] [Related]
32. Regulation of polarized morphogenesis by protein kinase C iota in oncogenic epithelial spheroids.
Linch M; Sanz-Garcia M; Rosse C; Riou P; Peel N; Madsen CD; Sahai E; Downward J; Khwaja A; Dillon C; Roffey J; Cameron AJ; Parker PJ
Carcinogenesis; 2014 Feb; 35(2):396-406. PubMed ID: 24072773
[TBL] [Abstract][Full Text] [Related]
33. Integrative genomic analysis of protein kinase C (PKC) family identifies PKCiota as a biomarker and potential oncogene in ovarian carcinoma.
Zhang L; Huang J; Yang N; Liang S; Barchetti A; Giannakakis A; Cadungog MG; O'Brien-Jenkins A; Massobrio M; Roby KF; Katsaros D; Gimotty P; Butzow R; Weber BL; Coukos G
Cancer Res; 2006 May; 66(9):4627-35. PubMed ID: 16651413
[TBL] [Abstract][Full Text] [Related]
34. Atypical protein kinase Cι as a human oncogene and therapeutic target.
Parker PJ; Justilien V; Riou P; Linch M; Fields AP
Biochem Pharmacol; 2014 Mar; 88(1):1-11. PubMed ID: 24231509
[TBL] [Abstract][Full Text] [Related]
35. Protein Kinase Cι Drives a NOTCH3-dependent Stem-like Phenotype in Mutant KRAS Lung Adenocarcinoma.
Ali SA; Justilien V; Jamieson L; Murray NR; Fields AP
Cancer Cell; 2016 Mar; 29(3):367-378. PubMed ID: 26977885
[TBL] [Abstract][Full Text] [Related]
36. The Proto-oncogene PKCι regulates the alternative splicing of Bcl-x pre-mRNA.
Shultz JC; Vu N; Shultz MD; Mba MU; Shapiro BA; Chalfant CE
Mol Cancer Res; 2012 May; 10(5):660-9. PubMed ID: 22522453
[TBL] [Abstract][Full Text] [Related]
37. PKCiota promotes ovarian tumor progression through deregulation of cyclin E.
Nanos-Webb A; Bui T; Karakas C; Zhang D; Carey JP; Mills GB; Hunt KK; Keyomarsi K
Oncogene; 2016 May; 35(19):2428-40. PubMed ID: 26279297
[TBL] [Abstract][Full Text] [Related]
38. Solution structure of atypical protein kinase C PB1 domain and its mode of interaction with ZIP/p62 and MEK5.
Hirano Y; Yoshinaga S; Ogura K; Yokochi M; Noda Y; Sumimoto H; Inagaki F
J Biol Chem; 2004 Jul; 279(30):31883-90. PubMed ID: 15143057
[TBL] [Abstract][Full Text] [Related]
39. Rab2 interacts directly with atypical protein kinase C (aPKC) iota/lambda and inhibits aPKCiota/lambda-dependent glyceraldehyde-3-phosphate dehydrogenase phosphorylation.
Tisdale EJ
J Biol Chem; 2003 Dec; 278(52):52524-30. PubMed ID: 14570876
[TBL] [Abstract][Full Text] [Related]
40. Protein kinase C (PKC) betaII induces cell invasion through a Ras/Mek-, PKC iota/Rac 1-dependent signaling pathway.
Zhang J; Anastasiadis PZ; Liu Y; Thompson EA; Fields AP
J Biol Chem; 2004 May; 279(21):22118-23. PubMed ID: 15037605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
